SCHEMBL17640395

SCHEMBL17640395

c1ccc(-c2nc(-c3ccc(N4c5ccccc5Sc5ccccc54)cc3)nn2-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ NR1H3 Q13133 3/20 0.40
▸ NR1H2 P55055 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KDM4A O75164 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ SENP8 Q96LD8 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17640507 1.00 HDAC6 (0.42) HDAC6SMN1; SMN2NR1H3NR1H2NPC1
SCHEMBL17640515 0.99 HDAC6 (0.43) HDAC6SMN1; SMN2NR1H3NR1H2NPC1
SCHEMBL17640408 0.99 HDAC6 (0.43) HDAC6SMN1; SMN2NR1H3NR1H2NPC1
SCHEMBL17640387 0.99 HDAC6 (0.43) HDAC6SMN1; SMN2NR1H3NR1H2NPC1
SCHEMBL17640412 0.97 HDAC6 (0.44) HDAC6SMN1; SMN2NR1H3NR1H2NPC1
SCHEMBL19499718 0.96 HDAC6 (0.45) HDAC6SMN1; SMN2NR1H3NR1H2NPC1
SCHEMBL17640417 0.91 HDAC6 (0.38) HDAC6SMN1; SMN2NR1H3NR1H2NPC1
SCHEMBL17640391 0.89 SMN1; SMN2 (0.48) SMN1; SMN2NR1H3NR1H2NPC1RAB9A
SCHEMBL17640503 0.89 SMN1; SMN2 (0.48) SMN1; SMN2NR1H3NR1H2NPC1RAB9A
SCHEMBL17640491 0.89 SMN1; SMN2 (0.48) SMN1; SMN2NR1H3NR1H2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 HDAC6 3454/4885SMN1; SMN2 3296/4885NR1H3 1274/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 HDAC6 3454/4885SMN1; SMN2 3296/4885NR1H3 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback